🇺🇸 ANI Pharmaceuticals, Inc.
Forum topic · ANIP · Company page: financials, ownership and filings
Join the discussion on ANI Pharmaceuticals, Inc.
Loading…
Results announced on 5 November 2026
ANI Pharmaceuticals, Inc. announced results on 5 November 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: revenue of $291 million (up 28% from a year earlier) and net income of $35 million (up 32% from a year earlier).
Insider trading in October 2026
Directors and officers of ANI Pharmaceuticals, Inc. reported open-market trades for October 2026 (SEC Forms 4 and 5): 3 insiders sold shares worth about $632,680 in 3 trades.
Awards, option exercises and shares withheld for tax are not counted.
Mutual funds: 247 funds hold $719 million
247 mutual funds in 2 countries hold shares of ANI Pharmaceuticals, Inc. worth $719 million, about 39.9% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 133 funds added shares and 69 sold; on balance they bought $68 million. Share splits are not counted as trading.
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.